Showing results (531-540 of 1,063) with videos related to

Sort By:
Pageof 107
Alzheimer'S & Dementia (New York, N. Y.)|October 13, 2022
The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendationsRachel L Nosheny, Rebecca Amariglio, Sietske A M Sikkes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 8, 2016
A multimodal approach to dementia prevention: A report from the Cambridge Institute of Public HealthOlawale Olanrewaju, Linda Clare, Linda Barnes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 24, 2015
Web-enabled Conversational Interactions as a Means to Improve Cognitive Functions: Results of a 6-Week Randomized Controlled TrialHiroko H Dodge, Jian Zhu, Nora Mattek, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 12, 2025
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations: Proceedings from the Alzheimer's Association Research Roundtable (AARR) Fall 2021 meetingRonald C Petersen, Ana Graf, Chris Brady, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 14, 2025
Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer's diseaseSarah M Hartz, Suzanne E Schindler, Marissa L Streitz, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 16, 2025
Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairmentChao-Yi Wu, Ashley C Kupferschmid, Liu Chen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2025
Evaluation of efficiency and effectiveness of different recruitment strategies for the FINGER-NL multidomain lifestyle intervention trial via the Dutch Brain Research RegistryLisa Waterink, Sietske A M Sikkes, Lion M Soons, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 17, 2025
LD-informed deep learning for Alzheimer's gene loci detection using WGS dataTaeho Jo, Paula Bice, Kwangsik Nho, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's diseaseWilliam Kielbasa, Paul Goldsmith, Kevin B Donnelly, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Alzheimer's disease drug development in an evolving therapeutic landscapeStacie Weninger, Michael C Irizarry, Adam S Fleisher, et al.
Pageof 107